Top

Patent and IP messes stifling biotech innovation too

The intellectual property morass doesn't just bog down the software and media industries. A panel formed by the McGill University Law School has spent seven years looking at the role of IP in the biotech industry, and finds many of the same problems occur there.

Read Full Story >>
arstechnica.com
The story is too old to be commented.